TY - JOUR
T1 - Laparoscopic versus robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer
T2 - A case control study
AU - Vizza, E.
AU - Corrado, G.
AU - Mancini, E.
AU - Vici, P.
AU - Sergi, D.
AU - Baiocco, E.
AU - Patrizi, L.
AU - Saltari, M.
AU - Pomati, G.
AU - Cutillo, G.
PY - 2015
Y1 - 2015
N2 - Objective: To compare the surgical outcome of robotic radical hysterectomy (RRH) versus laparoscopic radical hysterectomy (LRH) for the treatment of locally advanced cervical cancer (LACC) after neoadjuvant chemotherapy (NACT). Materials and methods: From August 1st 2010 to July 1st 2012 a prospective data collection of women undergoing RRH for cervical cancer stage FIGO IB2 to IIB, after neoadjuvant chemotherapy, was conducted at National Cancer Institute "Regina Elena" of Rome. All patients deemed operable underwent class C1 RRH with pelvic lymphadenectomy within 4 weeks from the last chemotherapy cycle. Results: A total of 25 RRH were analyzed, and compared with 25 historic LRH cases. The groups did not differ significantly in body mass index, stage, histology, number of pelvic lymph nodes removed. The median operative time was the same in the two groups with 190 min respectively. The median estimated blood loss (EBL) was statistically significant in favor of RRH group. Median length of stay was shorter, for the RRH group (4 versus 6 days, P 1/4 0.28). There was no significant difference in terms of intraoperative and postoperative complications between groups but in the RRH group we observed a greater number of total complications compared to the control group. Conclusion: This study shows that RRH is safe and feasible in LACC after NACT compare to LRH. However, a comparison of oncologic outcomes and costebenefit analysis is still needed and it has to be carefully evaluated in the future.
AB - Objective: To compare the surgical outcome of robotic radical hysterectomy (RRH) versus laparoscopic radical hysterectomy (LRH) for the treatment of locally advanced cervical cancer (LACC) after neoadjuvant chemotherapy (NACT). Materials and methods: From August 1st 2010 to July 1st 2012 a prospective data collection of women undergoing RRH for cervical cancer stage FIGO IB2 to IIB, after neoadjuvant chemotherapy, was conducted at National Cancer Institute "Regina Elena" of Rome. All patients deemed operable underwent class C1 RRH with pelvic lymphadenectomy within 4 weeks from the last chemotherapy cycle. Results: A total of 25 RRH were analyzed, and compared with 25 historic LRH cases. The groups did not differ significantly in body mass index, stage, histology, number of pelvic lymph nodes removed. The median operative time was the same in the two groups with 190 min respectively. The median estimated blood loss (EBL) was statistically significant in favor of RRH group. Median length of stay was shorter, for the RRH group (4 versus 6 days, P 1/4 0.28). There was no significant difference in terms of intraoperative and postoperative complications between groups but in the RRH group we observed a greater number of total complications compared to the control group. Conclusion: This study shows that RRH is safe and feasible in LACC after NACT compare to LRH. However, a comparison of oncologic outcomes and costebenefit analysis is still needed and it has to be carefully evaluated in the future.
KW - Locally advanced cervical cancer
KW - Minimally invasive surgery
KW - Neoadjuvant chemotherapy
KW - Robotic radical hysterectomy
UR - http://www.scopus.com/inward/record.url?scp=84922554251&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922554251&partnerID=8YFLogxK
U2 - 10.1016/j.ejso.2014.07.018
DO - 10.1016/j.ejso.2014.07.018
M3 - Article
C2 - 24063966
AN - SCOPUS:84922554251
VL - 41
SP - 142
EP - 147
JO - European Journal of Surgical Oncology
JF - European Journal of Surgical Oncology
SN - 0748-7983
IS - 1
ER -